Navigation Links
Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
Date:8/14/2012

ra-Apps are small pharmaceutically-sealed, tasteless, easy-use capsules in pocket-sized packaging that are designed to address the unique needs of today's millennial consumers.  Nutra-Apps provide premium science-based ingredients that have been characterized scientifically and shown to support an active lifestyle by enhancing energy, weight management, and relaxation*.  Nutra-Apps come in simple, "one-and-done" servings and are designed to fit comfortably in a pocket or purse for use anytime, anywhere. For information about MedPodium Nutra-Apps, please visit www.medpodium.com.  The video, "Nutra-Apps: Fuel your Lifestyle", is at http://www.youtube.com/watch?v=BtGqfI0Vfvs.

About CardiumCardium is an asset-based health sciences and regenerative medicine company focused on the acquisition and strategic development of innovative products and businesses with the potential to address significant unmet medical needs and having definable pathways to commercialization, partnering or other economic monetizations. Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the Company's in-house MedPodium Health Sciences healthy lifestyle product platform. The Company's lead commercial product Excellagen® topical gel for wound care management, recently received FDA clearance for marketing and sale in the United States.  Cardium's lead clinical development product candidate Generx® is a DNA-based angiogenic biologic intended for the treatment of patients with myocardial ischemia due to coronary artery disease. In addition, consistent with its capital-efficient business model, Cardium continues to actively evaluate new technologies and business opportunities. In July 2009, Cardium completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset mon
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
2. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
3. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
4. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
5. Inovio Initiates H1N1 Universal Influenza Vaccine Clinical Trial Targeting Over-65 Population, Which Represents 90% of Flu Deaths
6. Grant & Eisenhofer Represents Key Whistleblower in Justice Dept.s $1.04 Billion Civil Settlement with GlaxoSmithKline
7. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
8. Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinsons Disease
9. Frost & Sullivan: Developing Integration Capabilities Presents a Real Opportunity for Vendors in the European CIS Market
10. This Week: UBM Canon Presents an Online Event and Conference Dedicated to Emerging Trends in Medical Device Outsourcing/Contract Manufacturing
11. Berg Pharma presents at ASCO, poised to lead field in cancer metabolism with Phase II trials of BPM 31510
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... SPRING, Md. , April 21, 2015 /PRNewswire-USNewswire/ ... told the U.S. Food and Drug Administration that ... worked effectively for the last 25 years to ... to safe homeopathic medicines. AAHP, the industry,s trade ... and consumers of homeopathic medicines to engage in ...
(Date:4/21/2015)... 21, 2015 Delcath Systems, Inc. (NASDAQ: ... Trial Authorizations (CTAs) filed with the U.K.,s ... and Germany,s Federal Institute for ... the Company,s global Phase 2 program for the treatment ... or HCC), to include a cohort of patients with ...
(Date:4/21/2015)... , April 21, 2015   Mast ... biopharmaceutical company leveraging its molecular adhesion and sealant ... sickle cell disease, heart failure, and arterial disease, ... EPIC study of its lead product ... surpassed the halfway point. Consistent with prior guidance, ...
Breaking Medicine Technology:Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework 2Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 2Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 3Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic Cholangiocarcinoma 4Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 2Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 3Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 4Enrollment In Mast Therapeutics' Phase 3 "EPIC" Study In Sickle Cell Disease Surpasses Halfway Mark 5
... 3 Glufosfamide and Phase 2 Glufosfamide Plus ... Gemcitabine Clinical Trials to be Presented, REDWOOD CITY, Calif., ... announced two presentations,regarding its oncology product candidate glufosfamide. The presentations,will ... held,September 23 to 27, 2007, at the International Conference Center ...
... First Hsp90 Inhibitor to Enter Registration Trials, HAYWARD, ... ) today announced that it has successfully,reached a binding ... the design of its TIME-1 clinical trial, a pivotal ... treatment for patients with,multiple myeloma. Through the FDA,s Special ...
Cached Medicine Technology:Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 2Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO) 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7
(Date:4/21/2015)... (PRWEB) April 21, 2015 AvePoint, ... platforms and devices, today announced a new enhancement to ... the new Microsoft Office 365 Management Activity API. This ... to fully audit and take action on all events ... “The new Office 365 Management Activity API provides customers ...
(Date:4/21/2015)... released a new blog post explaining how to find ... are large vehicles that fare well in crash tests. A ... car shows that passengers from the first car have a ... but these large vehicles may be unstable and they may ... possible to find low cost car insurance plans on a ...
(Date:4/21/2015)... 21, 2015 Carinsurancehints.com has released a ... explaining their impact on auto insurance prices . ... auto insurance prices. Clients should review their insurance options ... be bought under several forms. Some of the popular ... rivers can compare online rates and find the best ...
(Date:4/21/2015)... 2015 Respected academic institution selects Visage ... , Visage Imaging Inc. (“Visage”), a wholly owned subsidiary ... a seven-year contract with University of Florida Health — ... The deal furthers the penetration of Visage 7 ... area of the North American enterprise imaging market. ...
(Date:4/21/2015)... Now in its fifteenth year, ... to unite over 3,000 senior attendees from across ... Suburban Collection Showplace on June 3 and 4. ... Ford, and Kia are set to deliver headline ... is reshaping automotive as connectivity paves the way ...
Breaking Medicine News(10 mins):Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 2Health News:AvePoint Integrates Microsoft Office 365 Management Activity API into DocAve Policy Enforcer for Proactive SharePoint Monitoring 3Health News:Auto Insurance Quotes For SUVs Are Available Online 2Health News:Heavily Circulated Roads Can increase Auto Insurance Costs 2Health News:Visage Imaging Signs University of Florida Health 2Health News:Visage Imaging Signs University of Florida Health 3Health News:Visage Imaging Signs University of Florida Health 4Health News:TU-Automotive Detroit 2015 Sample Attendee List Released 2Health News:TU-Automotive Detroit 2015 Sample Attendee List Released 3
... 2006 issue of the Journal of Adolescent Health by researchers// ... Miriam Hospital and Brown Medical School, suggests that as teens ... and increase their fast food consumption - both behaviors leads ... the transition from adolescence to adulthood appears to be a ...
... poultry farm in south western Japan in Kiyotake, around 750 ... ,This has been reported to the agricultural ministry ... out latest by Friday evening. If bird flu is confirmed, ... ,The farm in question has around 12000 ...
... to toddlers, parents need to be cautious as it may bring ... ,The Centre for Disease Control and Prevention in the US has ... children suffering from cold or cough without consulting their doctor. ... the age group of six months in 2005 revealed that they ...
... whose health and normal life was affected by a parrot was ... of Derbyshire who used to work for a pet shop had ... were very much like ordinary fever. But subsequent diagnosis revealed that ... he did not have direct contact with the sick African Grey ...
... the students gathered for a live chat with Indian American ... as she spoke from her zero-gravity// home among the stars, ... fact they had only read about in books before. ... and speak with three astronauts at the same platform - ...
... of data has revealed that more number of Canadians are ... decade ago. The recovery time for patients after// surgery is ... study of hospitalization and surgery rates undertaken by the Canadian ... patients in the healthcare system. The report showed that the ...
Cached Medicine News:Health News:Skipping Breakfast and Fast Food Consumption - Leads to Weight Gain 2Health News:Skipping Breakfast and Fast Food Consumption - Leads to Weight Gain 3Health News:Indian Students Thrilled to Talk to Sunita Williams 2
For use with: , pulmonary function testing , nebulizer compressors , humidifiers , concentrators , proximal pressure lines ...
... The Portex® Thermovent® T helps provide protection ... It is small and extremely lightweight making it ... adults. With a high rate of heat and ... secretion retention., ,All HMEs and filters have ...
... Thermovent® T helps provide protection to the exposed ... and extremely lightweight making it ideal for active ... high rate of heat and moisture recovery, it ... ,All HMEs and filters have ISO standard tapered ...
... The Portex® Thermovent® T helps provide protection to ... is small and extremely lightweight making it ideal ... With a high rate of heat and moisture ... retention., ,All HMEs and filters have ISO ...
Medicine Products: